{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:05:34Z","timestamp":1792677934298,"version":"4.5.0"},"reference-count":119,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease with insulin deficiency due to pancreatic \u03b2 cell destruction. Multiple independent cohort studies revealed specific lipid spectrum alterations prior to islet autoimmunity in T1DM. Except for serving as building blocks for membrane biogenesis, accumulative evidence suggests lipids and their derivatives can also modulate different biological processes in the progression of T1DM, such as inflammation responses, immune attacks, and \u03b2 cell vulnerability. However, the types of lipids are huge and majority of them have been largely unexplored in T1DM. In this review, based on the lipid classification system, we summarize the clinical evidence on dyslipidemia related to T1DM and elucidate the potential mechanisms by which they participate in regulating inflammation responses, modulating lymphocyte function and influencing \u03b2 cell susceptibility to apoptosis and dysfunction. This review systematically recapitulates the role and mechanisms of various lipids in T1DM, providing new therapeutic approaches for T1DM from a nutritional perspective.<\/jats:p>","DOI":"10.3389\/fimmu.2022.999108","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T09:59:30Z","timestamp":1665050370000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications"],"prefix":"10.3389","volume":"13","author":[{"given":"Jing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abh1654","article-title":"Immunotherapy: Building a bridge to a cure for type 1 diabetes","volume":"373","author":"Bluestone","year":"2021","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"Idf diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-0770","article-title":"Adult-onset type 1 diabetes: Current understanding and challenges","volume":"44","author":"Leslie","year":"2021","journal-title":"Diabetes Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12916-017-0958-6","article-title":"Fluctuations in the incidence of type 1 diabetes in the united states from 2001 to 2015: A longitudinal study","volume":"15","author":"Rogers","year":"2017","journal-title":"BMC Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5295","article-title":"Incidence of type 1 diabetes in China, 2010-13: Population based study","volume":"360","author":"Weng","year":"2018","journal-title":"BMJ"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2011.02410.x","article-title":"Being born in Sweden increases the risk for type 1 diabetes - a study of migration of children to Sweden as a natural experiment","volume":"101","author":"Soderstrom","year":"2012","journal-title":"Acta Paediatr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-003-1045-4","article-title":"Temporal changes in the frequencies of hla genotypes in patients with type 1 diabetes\u2013indication of an increased environmental pressure","volume":"46","author":"Hermann","year":"2003","journal-title":"Diabetologia"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3457","article-title":"Emerging effects of early environmental factors over genetic background for type 1 diabetes susceptibility: Evidence from a nationwide Italian twin study","volume":"97","author":"Nistico","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI122445","article-title":"Pahsas attenuate immune responses and promote beta cell survival in autoimmune diabetic mice","volume":"129","author":"Syed","year":"2019","journal-title":"J Clin Invest"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00784-6","article-title":"Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases","volume":"18","author":"Burg","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.860586","article-title":"Lipid metabolism: Immune regulation and therapeutic prospectives in systemic lupus erythematosus","volume":"13","author":"Sun","year":"2022","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1238","article-title":"Alterations in biomarkers related to glycemia, lipid metabolism, and inflammation up to 20 years before diagnosis of type 1 diabetes in adults: Findings from the amoris cohort","volume":"45","author":"Herzog","year":"2022","journal-title":"Diabetes Care"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081800","article-title":"Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes","volume":"205","author":"Oresic","year":"2008","journal-title":"J Exp Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2337\/db10-1652","article-title":"Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes","volume":"60","author":"Pflueger","year":"2011","journal-title":"Diabetes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"10635","DOI":"10.1038\/s41598-018-28907-8","article-title":"Dynamics of plasma lipidome in progression to islet autoimmunity and type 1 diabetes - type 1 diabetes prediction and prevention study (Dipp)","volume":"8","author":"Lamichhane","year":"2018","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"14819","DOI":"10.1038\/s41598-019-51251-4","article-title":"Metabolite-related dietary patterns and the development of islet autoimmunity","volume":"9","author":"Johnson","year":"2019","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e138034","DOI":"10.1172\/jci.insight.138034","article-title":"Lipid mediators and biomarkers associated with type 1 diabetes development","volume":"5","author":"Nelson","year":"2020","journal-title":"JCI Insight"},{"key":"B18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13059-021-02262-w","article-title":"Integrative analyses of teddy omics data reveal lipid metabolism abnormalities, increased intracellular ros and heightened inflammation prior to autoimmunity for type 1 diabetes","volume":"22","author":"Balzano-Nogueira","year":"2021","journal-title":"Genome Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/db20-0696","article-title":"Plasma metabolome and circulating vitamins stratified onset age of an initial islet autoantibody and progression to type 1 diabetes: The teddy study","volume":"70","author":"Li","year":"2021","journal-title":"Diabetes"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0215","article-title":"Decreased cord-blood phospholipids in young age-at-Onset type 1 diabetes","volume":"62","author":"La Torre","year":"2013","journal-title":"Diabetes"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05457-9","article-title":"The oxylipin profile is associated with development of type 1 diabetes: The diabetes autoimmunity study in the young (Daisy)","volume":"64","author":"Buckner","year":"2021","journal-title":"Diabetologia"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-022-01020-y","article-title":"Are clinicians aggressive enough in treating diabetes-related hyperlipidemia in youth","volume":"24","author":"Jackson","year":"2022","journal-title":"Curr Atheroscler Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002075","article-title":"Associations of insulin resistance and beta-cell function with abnormal lipid profile in newly diagnosed diabetes","volume":"135","author":"Tang","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.E400004-JLR200","article-title":"A comprehensive classification system for lipids","volume":"46","author":"Fahy","year":"2005","journal-title":"J Lipid Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0284","article-title":"Cellular production of n-3 pufas and reduction of n-6-to-N-3 ratios in the pancreatic beta-cells and islets enhance insulin secretion and confer protection against cytokine-induced cell death","volume":"59","author":"Wei","year":"2010","journal-title":"Diabetes"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.07.041","article-title":"Gpr120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI87388","article-title":"Omega-3 polyunsaturated fatty acids ameliorate type 1 diabetes and autoimmunity","volume":"127","author":"Bi","year":"2017","journal-title":"J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3390\/ijms19051446","article-title":"Sphingosine-1-Phosphate receptor 1 is involved in non-obese diabetic mouse thymocyte migration disorders","volume":"19","author":"Lemos","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.814491","article-title":"Overexpression of sphingosine-1-Phosphate lyase protects insulin-secreting cells against cytokine toxicity","volume":"292","author":"Hahn","year":"2017","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/11.6.473","article-title":"Sulfatide promotes the folding of proinsulin, preserves insulin crystals, and mediates its monomerization","volume":"11","author":"Osterbye","year":"2001","journal-title":"Glycobiology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.8.2514","article-title":"Sulfatide controls insulin secretion by modulation of atp-sensitive k(+)-channel activity and Ca(2+)-dependent exocytosis in rat pancreatic beta-cells","volume":"51","author":"Buschard","year":"2002","journal-title":"Diabetes"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2337\/db05-1355","article-title":"C16:0 sulfatide inhibits insulin secretion in rat beta-cells by reducing the sensitivity of katp channels to atp inhibition","volume":"55","author":"Buschard","year":"2006","journal-title":"Diabetes"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-743757","article-title":"Lysophosphatidic acid converts monocytes into macrophages in both mice and humans","volume":"129","author":"Ray","year":"2017","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2020.158641","article-title":"The roles of Autotaxin\/Lysophosphatidic acid in immune regulation and asthma","volume":"1865","author":"Kim","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"B35","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s13238-017-0423-5","article-title":"Structural and functional roles of ether lipids","volume":"9","author":"Dean","year":"2018","journal-title":"Protein Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/en.2015-1313","article-title":"Estrogen therapy delays autoimmune diabetes and promotes the protective efficiency of natural killer T-cell activation in female nonobese diabetic mice","volume":"157","author":"Gourdy","year":"2016","journal-title":"Endocrinology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2022.107250","article-title":"G Protein-coupled estrogen receptor activation by bisphenol-a disrupts the protection from apoptosis conferred by the estrogen receptors eralpha and erbeta in pancreatic beta cells","volume":"164","author":"Babiloni-Chust","year":"2022","journal-title":"Environ Int"},{"key":"B38","doi-asserted-by":"publisher","first-page":"211ra156","DOI":"10.1126\/scitranslmed.3006534","article-title":"Restoration of the unfolded protein response in pancreatic beta cells protects mice against type 1 diabetes","volume":"5","author":"Engin","year":"2013","journal-title":"Sci Transl Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2022.101165","article-title":"Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions","volume":"86","author":"Dyall","year":"2022","journal-title":"Prog Lipid Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.646491","article-title":"Effect of omega-3 polyunsaturated fatty acids-derived bioactive lipids on metabolic disorders","volume":"12","author":"Duan","year":"2021","journal-title":"Front Physiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/78.6.1128","article-title":"Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: A Large, population-based, case-control study","volume":"78","author":"Stene","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.12.1420","article-title":"Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes","volume":"298","author":"Norris","year":"2007","journal-title":"JAMA"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12170","article-title":"Effect of docosahexaenoic acid supplementation on inflammatory cytokine levels in infants at high genetic risk for type 1 diabetes","volume":"16","author":"Chase","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"B44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00125-013-3106-7","article-title":"Erythrocyte membrane docosapentaenoic acid levels are associated with islet autoimmunity: The diabetes autoimmunity study in the young","volume":"57","author":"Norris","year":"2014","journal-title":"Diabetologia"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2020.158823","article-title":"Lipidomic profiling of plasma free fatty acids in type-1 diabetes highlights specific changes in lipid metabolism","volume":"1866","author":"Sobczak","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41430-018-0185-z","article-title":"Intake of polyunsaturated fatty acids and risk of preclinical and clinical type 1 diabetes in children-a systematic review and meta-analysis","volume":"73","author":"Liu","year":"2019","journal-title":"Eur J Clin Nutr"},{"key":"B47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12933-020-01094-5","article-title":"Omega-3 polyunsaturated fatty acid supplementation versus placebo on vascular health, glycaemic control, and metabolic parameters in people with type 1 diabetes: A randomised controlled preliminary trial","volume":"19","author":"O'Mahoney","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.962773","article-title":"Effects of omega-3 supplementation on endothelial function, vascular structure, and metabolic parameters in adolescents with type 1 diabetes mellitus: A randomized clinical trial","volume":"9","author":"Khorshidi","year":"2022","journal-title":"Front Nutr"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-00409-6","article-title":"Revisiting the role of inflammation in the loss of pancreatic beta-cells in T1dm","volume":"16","author":"Eizirik","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2337\/db10-0901","article-title":"High pancreatic n-3 fatty acids prevent stz-induced diabetes in fat-1 mice: Inflammatory pathway inhibition","volume":"60","author":"Bellenger","year":"2011","journal-title":"Diabetes"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00454-y","article-title":"Pro-resolving lipid mediators: Regulators of inflammation, metabolism and kidney function","volume":"17","author":"Brennan","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3390\/ijms22041516","article-title":"Resolvin D1 decreases severity of streptozotocin-induced type 1 diabetes mellitus by enhancing bdnf levels, reducing oxidative stress, and suppressing inflammation","volume":"22","author":"Bathina","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0301-1","article-title":"Signaling networks in immunometabolism","volume":"30","author":"Saravia","year":"2020","journal-title":"Cell Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"353ra111","DOI":"10.1126\/scitranslmed.aaf7483","article-title":"Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses","volume":"8","author":"Chiurchi\u00f9","year":"2016","journal-title":"Sci Transl Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02241","article-title":"Therapeutic potential of omega-3 polyunsaturated fatty acids in human autoimmune diseases","volume":"10","author":"Li","year":"2019","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3390\/nu14091723","article-title":"Omega-3 fatty acids and their interaction with the gut microbiome in the prevention and amelioration of type-2 diabetes","volume":"14","author":"Kumar","year":"2022","journal-title":"Nutrients"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106342","article-title":"Omega-3 and cardiovascular prevention - is this still a choice","volume":"182","author":"Ruscica","year":"2022","journal-title":"Pharmacol Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.3390\/nu13072421","article-title":"Beneficial outcomes of omega-6 and omega-3 polyunsaturated fatty acids on human health: An update for 2021","volume":"13","author":"Djuricic","year":"2021","journal-title":"Nutrients"},{"key":"B59","doi-asserted-by":"publisher","first-page":"6965","DOI":"10.3390\/ijms22136965","article-title":"Effects of dietary n-3 and n-6 polyunsaturated fatty acids in inflammation and cancerogenesis","volume":"22","author":"Liput","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.035","article-title":"Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects","volume":"159","author":"Yore","year":"2014","journal-title":"Cell"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1172\/JCI127092","article-title":"Pahsas enhance hepatic and systemic insulin sensitivity through direct and indirect mechanisms","volume":"129","author":"Zhou","year":"2019","journal-title":"J Clin Invest"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2019.158576","article-title":"Exercise training induces insulin-sensitizing pahsas in adipose tissue of elderly women","volume":"1865","author":"Brezinova","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-Cd3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2047-61 e5","DOI":"10.1016\/j.stem.2021.10.003","article-title":"Implanted pluripotent stem-Cell-Derived pancreatic endoderm cells secrete glucose-responsive c-peptide in patients with type 1 diabetes","volume":"28","author":"Ramzy","year":"2021","journal-title":"Cell Stem Cell"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00101","article-title":"Endogenous pancreatic \u03b2 cell regeneration: A potential strategy for the recovery of \u03b2 cell deficiency in diabetes","volume":"10","author":"Zhong","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B66","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12974-022-02502-1","article-title":"Fatty acids role in multiple sclerosis as \"Metabokines\"","volume":"19","author":"Yu","year":"2022","journal-title":"J Neuroinflamm"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.06.040","article-title":"Significant abnormalities of the hdl phosphosphingolipidome in type 1 diabetes despite normal hdl cholesterol concentration","volume":"241","author":"Denimal","year":"2015","journal-title":"Atherosclerosis"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4614-2","article-title":"Abnormal islet sphingolipid metabolism in type 1 diabetes","volume":"61","author":"Holm","year":"2018","journal-title":"Diabetologia"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-1926-9","article-title":"Involvement of sulfatide in beta cells and type 1 and type 2 diabetes","volume":"48","author":"Buschard","year":"2005","journal-title":"Diabetologia"},{"key":"B70","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1084\/jem.20091619","article-title":"Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning","volume":"207","author":"Pham","year":"2010","journal-title":"J Exp Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s40265-021-01528-8","article-title":"Targeting sphingosine-1-Phosphate signaling in immune-mediated diseases: Beyond multiple sclerosis","volume":"81","author":"Perez-Jeldres","year":"2021","journal-title":"Drugs"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3296","article-title":"A map of the distribution of sphingosine 1-phosphate in the spleen","volume":"16","author":"Ramos-Perez","year":"2015","journal-title":"Nat Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.06.006","article-title":"Sphingolipids in metabolic disease: The good, the bad, and the unknown","volume":"33","author":"Green","year":"2021","journal-title":"Cell Metab"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/nature02284","article-title":"Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1p receptor 1","volume":"427","author":"Matloubian","year":"2004","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.11.017","article-title":"S1p1 receptor signaling overrides retention mediated by G alpha I-coupled receptors to promote T cell egress","volume":"28","author":"Pham","year":"2008","journal-title":"Immunity"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107971","article-title":"Lessons from S1p receptor targeting in multiple sclerosis","volume":"230","author":"Colombo","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M610318200","article-title":"Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor","volume":"282","author":"Oo","year":"2007","journal-title":"J Biol Chem"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00381","article-title":"Abnormal T-cell development in the thymus of non-obese diabetic mice: Possible relationship with the pathogenesis of type 1 autoimmune diabetes","volume":"9","author":"Mendes-da-Cruz","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.2337\/db07-0855","article-title":"Sphingosine-1-Phosphate reduces Cd4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and Cd69","volume":"57","author":"Srinivasan","year":"2008","journal-title":"Diabetes"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-263194","article-title":"Sphingosine 1-phosphate counteracts insulin signaling in pancreatic beta-cells Via the sphingosine 1-phosphate receptor subtype 2","volume":"29","author":"Japtok","year":"2015","journal-title":"FASEB J"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3390\/ijms23031638","article-title":"To be or not to be: The divergent action and metabolism of sphingosine-1 phosphate in pancreatic beta-cells in response to cytokines and fatty acids","volume":"23","author":"Gurgul-Convey","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12157","article-title":"Administration of sulfatide to ameliorate type I diabetes in non-obese diabetic mice","volume":"79","author":"Rhost","year":"2014","journal-title":"Scand J Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-04973-z","article-title":"Fenofibrate increases very-Long-Chain sphingolipids and improves blood glucose homeostasis in nod mice","volume":"62","author":"Holm","year":"2019","journal-title":"Diabetologia"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0463.2003.1110905.x","article-title":"Selective lack of the C16:0 fatty acid isoform of sulfatide in pancreas of type ii diabetic animal models","volume":"111","author":"Blomqvist","year":"2003","journal-title":"APMIS"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0656","article-title":"Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants","volume":"62","author":"Sosenko","year":"2013","journal-title":"Diabetes"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.04.059","article-title":"Triglycerides and residual atherosclerotic risk","volume":"77","author":"Raposeiras-Roubin","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"key":"B88","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tem.2020.11.005","article-title":"Lipoprotein lipase and its regulators: An unfolding story","volume":"32","author":"Wu","year":"2021","journal-title":"Trends Endocrinol Metab"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-019-01387-6","article-title":"Pathophysiological characteristics in patients with latent autoimmune diabetes in adults using clamp tests: Evidence of a continuous disease spectrum of diabetes","volume":"56","author":"Yang","year":"2019","journal-title":"Acta Diabetol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05611-3","article-title":"Associations of plasma glycerophospholipid profile with modifiable lifestyles and incident diabetes in middle-aged and older Chinese","volume":"65","author":"Chen","year":"2022","journal-title":"Diabetologia"},{"key":"B91","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41392-020-00367-5","article-title":"Role of lysophosphatidic acid and its receptors in health and disease: Novel therapeutic strategies","volume":"6","author":"Geraldo","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-050420-025929","article-title":"Lysophospholipid mediators in health and disease","volume":"17","author":"Kano","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"102327","DOI":"10.1016\/j.jaut.2019.102327","article-title":"Autotaxin and chronic inflammatory diseases","volume":"104","author":"Magkrioti","year":"2019","journal-title":"J Autoimmun"},{"key":"B94","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41392-020-00379-1","article-title":"Lysophosphatidic acid mediates the pathogenesis of psoriasis by activating keratinocytes through Lpar5","volume":"6","author":"Lei","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-020-02130-x","article-title":"Activation of macrophages by lysophosphatidic acid through the lysophosphatidic acid receptor 1 as a novel mechanism in multiple sclerosis pathogenesis","volume":"58","author":"Fransson","year":"2021","journal-title":"Mol Neurobiol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-007-0269-z","article-title":"Lysophosphatidic acid regulates blood glucose by stimulating myotube and adipocyte glucose uptake","volume":"86","author":"Yea","year":"2008","journal-title":"J Mol Med (Berl)"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-2891-3","article-title":"Lysophosphatidic acid impairs glucose homeostasis and inhibits insulin secretion in high-fat diet obese mice","volume":"56","author":"Rancoule","year":"2013","journal-title":"Diabetologia"},{"key":"B98","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.3390\/ijms23084163","article-title":"Glucagon-like peptide-1 secretion is inhibited by lysophosphatidic acid","volume":"23","author":"Fernandes","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101493","article-title":"Autotaxin signaling facilitates beta cell dedifferentiation and dysfunction induced by sirtuin 3 deficiency","volume":"60","author":"Cao","year":"2022","journal-title":"Mol Metab"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/ni1573","article-title":"Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs","volume":"9","author":"Kanda","year":"2008","journal-title":"Nat Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-00443-4","article-title":"Type 1 diabetes mellitus as a disease of the beta-cell (Do not blame the immune system?)","volume":"17","author":"Roep","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2016.12.005","article-title":"Beta-cell fragility as a common underlying risk factor in type 1 and type 2 diabetes","volume":"23","author":"Liston","year":"2017","journal-title":"Trends Mol Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.841278","article-title":"Ether lipids in obesity: From cells to population studies","volume":"13","author":"Schooneveldt","year":"2022","journal-title":"Front Physiol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2020.01.015","article-title":"Dyslipidemia in type 1 diabetes: Amaskeddanger","volume":"31","author":"Verges","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05509-0","article-title":"Hdl and type 2 diabetes: The chicken or the egg","volume":"64","author":"Xepapadaki","year":"2021","journal-title":"Diabetologia"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2017.08.016","article-title":"Gender differences in glucose homeostasis and diabetes","volume":"187","author":"Mauvais-Jarvis","year":"2018","journal-title":"Physiol Behav"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2007.01896.x","article-title":"Gender differences and temporal variation in the incidence of type 1 diabetes: Results of 8012 cases in the nationwide diabetes incidence study in Sweden 1983-2002","volume":"263","author":"Ostman","year":"2008","journal-title":"J Intern Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2017.07.015","article-title":"Are estrogens promoting immune modulation and islet protection in type 1 diabetes","volume":"31","author":"Mauvais-Jarvis","year":"2017","journal-title":"J Diabetes Complications"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13078","article-title":"Oestrogen activity of the serum in adolescents with type 1 diabetes","volume":"33","author":"Martinez","year":"2016","journal-title":"Diabetes Med"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnac017","article-title":"Estrogen receptor signaling in the immune system","author":"Chakraborty","year":"2022","journal-title":"Endocr Rev"},{"key":"B111","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jneuroim.2016.02.009","article-title":"Estrogen induces multiple regulatory b cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis","volume":"293","author":"Benedek","year":"2016","journal-title":"J Neuroimmunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/srep44270","article-title":"Self-renewal and phenotypic conversion are the main physiological responses of macrophages to the endogenous estrogen surge","volume":"7","author":"Pepe","year":"2017","journal-title":"Sci Rep"},{"key":"B113","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/bs.ircmb.2021.02.004","article-title":"Sexual hormones and diabetes: The impact of estradiol in pancreatic beta cell","volume":"359","author":"Merino","year":"2021","journal-title":"Int Rev Cell Mol Biol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.3390\/ijms23126693","article-title":"Estradiol (E2) improves glucose-stimulated insulin secretion and stabilizes gdm progression in a prediabetic mouse model","volume":"23","author":"Liebmann","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0266-7","article-title":"Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs","volume":"15","author":"Ahmad","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab400","article-title":"Prediction of type 1 diabetes at birth: Cord blood metabolites vs genetic risk score in the Norwegian mother, father, and child cohort","volume":"106","author":"Tapia","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2391188","article-title":"Serum bile acid profiles in latent autoimmune diabetes in adults and type 2 diabetes patients","volume":"2022","author":"Zhou","year":"2022","journal-title":"J Diabetes Res"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S288011","article-title":"Cinnamaldehyde improves metabolic functions in streptozotocin-induced diabetic mice by regulating gut microbiota","volume":"15","author":"Zhao","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.01.004","article-title":"Control of immunity Via nutritional interventions","volume":"55","author":"Collins","year":"2022","journal-title":"Immunity"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.999108\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T09:59:33Z","timestamp":1665050373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.999108\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":119,"alternative-id":["10.3389\/fimmu.2022.999108"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.999108","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,6]]},"article-number":"999108"}}